Name of the course: TREOCAPA Trial Phase II Protocol training
Edition of the course: 1st Edition
Course enrollment: Enrollment is available for the duration of the trial
If you are involved in TTREOCAPA Trial, please contact your National Hub to enrol.
Your National Hub’s Referent Person for Training and Education will verify your eligibility and provide you with the course’s enrolment password.
Once you receive the password, please log in on the c4c Academy platform. If you do not have an account yet, click “Create new account” and follow the instructions
Course Duration: 15 minutes
General Description:
This course presents the key components of the TREOCAPA Trial Phase II Protocol.
Programme:
- Time for parents information
- Patient selection
- Inclusion procedure and collection of informed consent
- Phase II study design
- Blood samples for PK
- AE / SAE monitoring
- Patient withdrawal
Who is the course for?
This training is intended for co-investigators and research teams of sites participating in the Phase II study, especially those who might not be able to participate in the site initiation visit, and to any new research staff member who might join the team of the investigational site during the course of the trial.
This training is also intended for staff who will be organizing the site initiation visits (train the trainers).
This relates to 10 NICUs across France, UK, Finland and Denmark.
Max. number of persons that each national hub can enrol: 30
Bloom’s taxonomy level of the course:
Faculty:
Jean-Christophe Roze: jeanchristophe.roze@chu-nantes.fr
Anne Chauviré-Drouard: Anne.DROUARD@chu-nantes.fr
Anaëlle Moal: Anaelle.moal@inserm.fr
